MAP
Moody Aldrich Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Sell |
120,703
-61,868
| -34% | -$1.34M | 0.51% | 82 |
|
|
2025
Q1 | $4.43M | Sell |
182,571
-33,086
| -15% | -$802K | 0.93% | 43 |
|
|
2024
Q4 | $4.5M | Sell |
215,657
-60,990
| -22% | -$1.27M | 0.83% | 50 |
|
|
2024
Q3 | $5.5M | Sell |
276,647
-5,427
| -2% | -$108K | 1% | 38 |
|
|
2024
Q2 | $4.37M | Sell |
282,074
-18,877
| -6% | -$292K | 0.85% | 55 |
|
|
2024
Q1 | $4.8M | Sell |
300,951
-6,961
| -2% | -$111K | 0.82% | 53 |
|
|
2023
Q4 | $5.18M | Buy |
307,912
+34,400
| +13% | +$578K | 0.93% | 41 |
|
|
2023
Q3 | $3.2M | Buy |
273,512
+11,075
| +4% | +$129K | 0.61% | 68 |
|
|
2023
Q2 | $3.53M | Buy |
262,437
+60,355
| +30% | +$811K | 0.69% | 59 |
|
|
2023
Q1 | $3.35M | Buy |
+202,082
| New | +$3.35M | 0.68% | 64 |
|